TherapeuticsMD Stock Price

0.015 (1.44%)
Upgrade to Real-Time
Regular Market


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
TherapeuticsMD Inc TXMD NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.015 1.44% 1.055 13:49:06
Open Price Low Price High Price Close Price Prev Close
1.04 1.00 1.06 1.04
Bid Price Ask Price Spread News
1.05 1.06 0.01 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,838 1,975,490 $ 1.04 $ 2,052,400 - 0.93 - 2.75
Last Trade Time Type Quantity Stock Price Currency
13:50:31 5 $ 1.0555 USD


Draw Mode:

TherapeuticsMD Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 414.82M 393.19M 366.92M $ 64.87M $ - -0.67 -1.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -177.64k 6.30%

more financials information »

TherapeuticsMD News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TXMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.001.080.931.023,485,5170.0555.5%
1 Month1.221.250.931.105,823,776-0.165-13.52%
3 Months1.201.390.931.166,188,109-0.145-12.08%
6 Months1.632.750.931.5110,905,959-0.575-35.28%
1 Year2.102.750.931.487,416,014-1.05-49.76%
3 Years6.526.940.8532.264,905,248-5.47-83.82%
5 Years5.257.660.8532.724,448,366-4.20-79.9%

TherapeuticsMD Description

TherapeuticsMD Inc is a major drug manufacturing with a focus on creating and commercializing products targeted exclusively for women. The company intends to commercialize advanced hormone therapy pharmaceutical products. TherapeuticsMD's drug candidates that have completed clinical trials are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and discomfort. The company relies on third parties for the production of clinical and commercial quantities of its drug candidates.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.